| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0008600 | Exon-Exon | chr3:171830242-171905080 | chr3:172112452-172187290 | 250 nt | 0.2920 |
| hsa_FNDC3B_0006600 | Exon-Exon | chr3:171830242-171944737 | chr3:172112452-172226947 | 292 nt | 0.4829 |
| hsa_FNDC3B_0006700 | Exon-Exon | chr3:171830242-171969331 | chr3:172112452-172251541 | 818 nt | 0.4976 |
| hsa_FNDC3B_0006800 | Exon-Exon | chr3:171830242-172055191 | chr3:172112452-172337401 | 1880 nt | 0.4809 |
| hsa_FNDC3B_0006900 | Exon-Exon | chr3:171830242-172064230 | chr3:172112452-172346440 | 2392 nt | 0.4929 |
| hsa_FNDC3B_0007000 | Exon-Exon | chr3:171830242-172065151 | chr3:172112452-172347361 | 2542 nt | 0.4902 |
| hsa_FNDC3B_0007100 | Exon-Exon | chr3:171830242-172096226 | chr3:172112452-172378436 | 250 nt | 0.4160 |
| hsa_FNDC3B_0007200 | Exon-Exon | chr3:171830242-172098883 | chr3:172112452-172381093 | 250 nt | 0.3640 |
| hsa_FNDC3B_0007300 | Exon-Exon | chr3:171830242-172118492 | chr3:172112452-172400702 | 250 nt | 0.3000 |
| hsa_FNDC3B_0010000 | Exon-Exon | chr3:171851261-171851336 | chr3:172133471-172133546 | 76 nt | 0.4079 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].